Arkolith/Insider Trading/URGN/Form 4

Schoenberg Mark

Chief Medical OfficerUroGen Pharma Ltd. (URGN) · full profile →Form 4 · filed Jul 30, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$99K
Net Open-Market Flow
-$99K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 28, 2025Sell(S)5K$19.14$99K158K
Jul 28, 2025Option exercise(M)10K——163K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-25-023961) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML